CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 300 enrolled
Drug / intervention
Misoprostol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02012491
NCT02012491Phase 3Completed
CompareCT.gov

Comparative Effectiveness of Pregnancy Failure Management Regimens

University of Pennsylvania·interventional·Posted Dec 16, 2013·Updated Jul 18, 2019

In Brief

A Phase 3 clinical trial evaluating Misoprostol and Mifepristone for Spontaneous Abortion. Completed, enrolled 300 participants across 3 sites.

Detailed Summary

The purpose of the study is to compare the effectiveness of combination treatment (mifepristone premedication plus single-dose misoprostol) to single-dose misoprostol (standard of care) for the management of early pregnancy failure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpontaneous Abortion
CountriesUnited States
CollaboratorsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Timeline

Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 16, 2013
Enrollment StartJan 1, 2014
Primary CompletionMay 15, 2017
Study CompletionJun 15, 2019
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 12.5 years ago

Interventions

Misoprostoldrug

Mifepristonedrug